Vascular calcification in uremic conditions: New insights into pathogenesis

Seminars in Nephrology

Volumn 26, Issue 1, 2006, Pages 33-37

  Cozzolino, Mario ^a   Gallieni, Maurizio ^a   Brancaccio, Diego ^a  

^a SAN PAOLO HOSPITAL   (Italy)

Author keywords

BMP 7; Chronic kidney disease; Extraskeletal calcification; Fetuin; MGP

Indexed keywords

ALUMINUM; BETA1 INTEGRIN; CALCIUM; FETUIN; MATRIX PROTEIN; MINERAL; OSTEOCALCIN; OSTEOGENIC PROTEIN 1; PARATHYROID HORMONE; PHOSPHATE; PHOSPHATE BINDING AGENT; PROTEIN MATRIX 7; UNCLASSIFIED DRUG; VITAMIN K GROUP;

BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; HEMODIALYSIS; HUMAN; MORBIDITY; MORTALITY; NONHUMAN; PATHOGENESIS; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; REVIEW; SOFT TISSUE CALCIFICATION; UREMIA;

EID: 30444439865     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2005.06.008     Document Type: Article

References (46)

1. R.C. Christian, L.A. Fitzpatrick Vascular calcification Curr Opin Nephrol Hypertens 8 1999 443 448
2. A. Ansari, C.J. Kaupke, N.D. Vaziri Cardiac pathology in patients with end-stage renal disease maintained on hemodialysis Int J Artif Organs 16 1993 31 36
3. U. Schwarz, M. Buzello, E. Ritz Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure Nephrol Dial Transplant 15 2000 218 223
4. G.M. London Cardiovascular calcifications in uremic patients Clinical impact on cardiovascular function J Am Soc Nephrol 14 2003 S305 S309
5. G.M. London, A.P. Guerin, S.J. Marchais Arterial media calcification in end-stage renal disease Impact on all-cause and cardiovascular mortality Nephrol Dial Transplant 18 2003 1731 1740
6. J. Blacher, M.E. Safar, A.P. Guerin Aortic pulse wave velocity index and mortality in end-stage renal disease Kidney Int 63 2003 1852 1860
7. R. Vattikuti, D.A. Towler Osteogenic regulation of vascular calcification An early perspective Am J Physiol 286 2004 E686 E696
8. M.G.T. Jakoby, C.F. Semenkovich The role of osteoprogenitors in vascular calcification Curr Opin Nephrol Hypertens 9 2000 11 15
9. M. Cozzolino, A.S. Dusso, E. Slatopolsky Role of calcium-phosphate product and bone-associated proteins on vascular calcification in renal failure J Am Soc Nephrol 12 2001 2511 2516
10. G.A. Block, T.E. Hulbert-Shearon, N.W. Levin Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients A national study Am J Kidney Dis 31 1998 607 617
11. S.K. Ganesh, A.G. Stack, N.W. Levin Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients J Am Soc Nephrol 12 2001 2131 2138
12. M. Cozzolino, D. Brancaccio, M. Gallieni Pathogenesis of vascular calcification in chronic kidney disease Kidney Int 68 2005 429 436
13. G.A. Block, F.K. Port Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients Recommendations for a change in management Am J Kidney Dis 35 2000 1226 1237
14. W.G. Goodman, J. Goldin, B.D. Kuizon Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis N Engl J Med 342 2000 1478 1483
15. M. Cozzolino, A.S. Dusso, H. Liapis The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats J Am Soc Nephrol 13 2002 2299 2308
16. M. Cozzolino, M.E. Staniforth, H. Liapis Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia Kidney Int 64 2003 1653 1661
17. G.M. Chertow, S.K. Burke, P. Raggi Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients Kidney Int 62 2002 245 252
18. S. Jono, M.D. McKee, C.E. Murry Phosphate regulation of vascular smooth muscle cell calcification Circ Res 87 2000 E10 E17
19. C.M. Giachelli Ectopic calcification New concepts in cellular regulation Z Kardiol 90 suppl 3 2001 31 37
20. P. Ducy, R. Zhang, V. Geoffroy Osf2/Cbfa1 A transcriptional activator of osteoblast differentiation Cell 89 1997 747 754
21. N.X. Chen, K.D. O'Neill, D. Duan Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells Kidney Int 62 2002 1724 1731
22. S.M. Moe, D. Duan, B.P. Doehle Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels Kidney Int 63 2003 1003 1011
23. R.J. Lund, M.R. Davies, K. Hruska Bone morphogenetic protein-7 An anti-fibrotic morphogenetic protein with therapeutic importance in renal disease Curr Opin Nephrol Hypertens 11 2002 31 36
24. M.R. Davies, R.J. Lund, K.A. Hruska BMP-7 is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure J Am Soc Nephrol 14 2003 1559 1567
25. T. Li, K. Surendran, M.A. Zawaideh Bone morphogenetic protein 7 A novel treatment for chronic renal and bone disease Curr Opin Nephrol Hypertens 13 2004 417 422
26. G. Luo, C. Hofmann, A.L. Bronckers BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning Genes Dev 9 1995 2808 2820
27. S.-N. Wang, J. Lapage, R. Hirschberg Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy J Am Soc Nephrol 12 2001 2392 2399
28. S. Wang, Q. Chen, T.C. Simon Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy Kidney Int 63 2003 2037 2049
29. H. Dorai, S. Vukicevic, T.K. Sampath Bone morphogenetic protein-7 (osteogenic protein-1) inhibits smooth muscle cell proliferation and stimulates the expression of markers that are characteristic of SMC phenotype in vitro J Cell Physiol 184 2000 37 45
30. R.J. Lund, M.R. Davies, A.J. Brown Successful treatment of an adynamic bone disorder with bone morphogenetic protein-7 in a renal ablation model J Am Soc Nephrol 15 2004 359 369
31. B.L.M. Hogan Bone morphogenetic proteins Multifunctional regulators of vertebrate development Genes Dev 10 1996 1580 1594
32. A.M. Baskies, P.B. Chretien, J.F. Weiss Serum glycoproteins in cancer patients First report of correlations with in vitro and in vivo parameters of cellular immunity Cancer 45 1980 3050 3060
33. A. Heiss, A. DuChesne, B. Denecke Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles J Biol Chem 278 2003 13333 13341
34. M. Demetriou, C. Binker, B. Sukhu Fetuin/alpha2-HS glycoprotein is a transforming growth factor beta type II receptor mimic and cytokine antagonist J Biol Chem 271 1996 12755 12761
35. C. Schafer, A. Heiss, A. Schwarz The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification J Clin Invest 112 2003 357 366
36. M. Ketteler, P. Bongartz, R. Westenfeld Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis A cross-sectional study Lancet 361 2003 827 833
37. P.A. Price, J.M. Caputo, M.K. Williamson Bone origin of the serum complex of calcium, phosphate, fetuin, and matrix Gla protein Biochemical evidence for the cancellous bone-remodeling compartment J Bone Miner Res 17 2002 1171 1179
38. P.A. Price, J.E. Lim The inhibition of calcium phosphate precipitation by fetuin is accompanied by the formation of a fetuin-mineral complex J Biol Chem 278 2003 22144 22152
39. P.A. Price, M.K. Williamson, T.M. Nguyen Serum levels of the fetuin mineral complex correlate with artery calcification in the rat J Biol Chem 279 2004 1594 1600
40. G. Luo, P. Ducy, M.D. McKee Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein Nature 386 1997 78 81
41. M.J. Shearer Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification Curr Opin Clin Nutr Metab Care 3 2000 433 438
42. A.F. Zebboudj, V. Shin, K. Bostrom Matrix GLA protein and BMP-2 regulate osteoinduction in calcifying vascular cells J Cell Biochem 90 2003 756 765
43. N. Wajih, T. Borras, W. Xue Processing and transport of matrix Gla protein (MGP) and bone morphogenetic protein-2 (BMP-2) in cultured human vascular smooth muscle cells Evidence for an uptake mechanism for serum fetuin J Biol Chem 279 2004 43052 43060
44. A.E. Canfield, C. Farrington, M.D. Dziobon The involvement of matrix glycoproteins in vascular calcification and fibrosis an immunohistochemical study J Pathol 196 2002 228 234
45. S.-M. Hermann, C. Whatling, E. Brand Polymorphisms of the human matrix Gla protein (MGP) gene, vascular calcification, and myocardial infarction Arterioscler Thromb Vasc Biol 20 2000 2386 2393
46. S. Jono, Y. Ikari, C. Vermeer Matrix Gla protein is associated with coronary artery calcification as assessed by electron-beam computed tomography Thromb Haemost 91 2004 790 794